# Real-life Evaluation of WEGOVY (Semaglutide) Treatment in Adults With Monogenic Obesity (ObGeSema)

> **NCT06380426** · — · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 175 (estimated)

## Conditions studied

- Monogenic Obesity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06380426
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-19
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-11-30
- **Target enrollment:** 175 (ESTIMATED)
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06380426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06380426, "Real-life Evaluation of WEGOVY (Semaglutide) Treatment in Adults With Monogenic Obesity (ObGeSema)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06380426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*